Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '25 Jul 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Market Capitalization	1	1	1	-	-
Market Cap Growth	-34.85%	13.14%	-	-	-
Enterprise Value	1	1	1	-	-
Last Close Price	0.02	0.04	0.06	-	-
PB Ratio	1.58	2.84	4.39	-	-
P/TBV Ratio	1.58	2.84	4.39	-	-
Debt / Equity Ratio	0.80	0.51	0.56	-	-
Quick Ratio	0.05	0.08	0.78	0.40	5.48
Current Ratio	0.06	0.09	0.81	0.52	5.70
Return on Equity (ROE)	-79.76%	-171.88%	-158.04%	-70.50%	-
Return on Assets (ROA)	-41.88%	-62.48%	-40.50%	-32.93%	-
Return on Capital (ROIC)	-46.04%	-80.10%	-51.70%	-46.75%	-
Earnings Yield	-52.36%	-47.52%	-27.18%	-	-
FCF Yield	-127.39%	-86.65%	-42.68%	-	-
Buyback Yield / Dilution	-110.26%	-98.95%	-35.11%	-53.93%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.